Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

BENYLIN

DIPHENHYDRAMINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE

Standard Dose
12.5MG/5ML;30MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview BENYLIN is listed in Drugs@FDA under application 019014 (NDA).

Marketing status: Discontinued Active ingredient DIPHENHYDRAMINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE Form and strength SOLUTION;ORAL - 12.5MG/5ML;30MG/5ML Sponsor PARKE DAVIS Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview BENYLIN is listed in Drugs@FDA under application 019014 (NDA). Marketing status: Discontinued Active ingredient DIPHENHYDRAMINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE Form and strength SOLUTION;ORAL - 12.5MG/5ML;30MG/5ML Sponsor PARKE DAVIS Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
BENYLIN (DIPHENHYDRAMINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE) | Drug Monograph | MedicHelpline